Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 2/20 | 0.66 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.66 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.66 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.56 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.56 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 11/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | GBA1 | P04062 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9801112 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801462 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801513 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801024 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801263 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801333 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801904 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL1485554 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL9801953 | 1.00 | GNAI3 (0.66) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL6322490 | 0.98 | GNAI3 (0.63) | GNAI3GNAO1GNAI1S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3404056-B1 | METHOD FOR PRODUCING THERMOPLASTIC ELASTOMER COMPOSITION | ZEON CORP (JP) | 2025-06-11 | — | — | EP | disclosed |
| EP-3101065-B1 | CROSS-LINKABLE NITRILE RUBBER COMPOSITION AND CROSS-LINKED RUBBER | ZEON CORP (JP) | 2025-05-28 | — | — | EP | disclosed |
| US-12202923-B2 | Nitrile-group-containing copolymer rubber | ZEON CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| CN-114555660-B | Nitrile group-containing copolymer rubber | 日本瑞翁株式会社 | 2024-06-11 | — | — | CN | disclosed |
| EP-3744739-B1 | METHOD FOR PRODUCING CARBOXY GROUP-CONTAINING HYDROGENATED NITRILE RUBBER | ZEON CORP (JP) | 2023-12-27 | — | — | EP | disclosed |
| EP-3305817-B2 | NITRILE GROUP CONTAINING, HIGHLY SATURATED COPOLYMER RUBBER | ZEON CORP (JP) | 2023-12-27 | — | — | EP | disclosed |
| US-11639408-B2 | Nitrile group-containing copolymer rubber | ZEON CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| EP-3604433-B1 | CROSSLINKABLE RUBBER COMPOSITION AND CROSSLINKED RUBBER OBJECT | ZEON CORP (JP) | 2023-04-19 | — | — | EP | disclosed |
| EP-3176190-B1 | NITRILE-GROUP-CONTAINING COPOLYMER RUBBER, CROSSLINKABLE RUBBER COMPOSITION, AND CROSSLINKED RUBBER | ZEON CORP (JP) | 2023-03-29 | — | — | EP | disclosed |
| EP-3816221-B1 | CROSSLINKABLE NITRILE RUBBER COMPOSITION AND CROSSLINKED RUBBER MATERIAL | ZEON CORP (JP) | 2023-02-15 | — | — | EP | disclosed |
| US-20170166672-A1 | NITRILE GROUP-CONTAINING COPOLYMER RUBBER, CROSS-LINKABLE RUBBER COMPOSITION, AND CROSS-LINKED RUBBER | ZEON CORPORATION (JP) | 2017-06-15 | — | — | US | disclosed |
| EP-3176190-A1 | NITRILE-GROUP-CONTAINING COPOLYMER RUBBER, CROSSLINKABLE RUBBER COMPOSITION, AND CROSSLINKED RUBBER | Zeon Corporation (JP) | 2017-06-07 | — | — | EP | disclosed |
| EP-2902437-B1 | CROSSLINKABLE RUBBER COMPOSITION AND CROSSLINKED RUBBER | ZEON CORP (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-20170009051-A1 | CROSS-LINKABLE NITRILE RUBBER COMPOSITION AND CROSS-LINKED RUBBER | ZEON CORPORATION (JP) | 2017-01-12 | — | — | US | disclosed |
| EP-3101065-A1 | CROSS-LINKABLE NITRILE RUBBER COMPOSITION AND CROSS-LINKED RUBBER | Zeon Corporation (JP) | 2016-12-07 | — | — | EP | disclosed |
| US-9458275-B2 | Cross-linkable rubber composition and cross-linked rubber | ZEON CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20150246991-A1 | CROSS-LINKABLE RUBBER COMPOSITION AND CROSS-LINKED RUBBER | ZEON CORPORATION (JP) | 2015-09-03 | — | — | US | disclosed |
| EP-2902437-A1 | CROSSLINKABLE RUBBER COMPOSITION AND CROSSLINKED RUBBER | Zeon Corporation (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-20100130581-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | THE UNIVERSITY OF QUEENSLAND | 2010-05-27 | — | — | US | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130581-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | OPRL1, CRH, OPRK1 | GNAI3 1991/4885GNAO1 1287/4885GNAI1 2773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.